Search the Newsreel

Pfizer Earnings: Strong Growth for Newer Drugs Counters Covid Declines

Pfizer reported 3% revenue growth in the second quarter and maintained its adjusted diluted EPS guidance for 2026, leading to a 2% rise in shares. The company's newer drugs like Nurtec, Lorbrena, and Padcev are driving growth, offsetting reduced demand for COVID-19 products. Morningstar …

Can TechnipFMC's Q2 Subsea Momentum Power Stronger 2026 Results Ahead?

TechnipFMC (FTI) delivered strong second-quarter results, driven by higher Subsea activity which boosted earnings, margins, and cash flow. While the company's outlook for 2026 points to continued strength, particularly in the Subsea segment, weaknesses in Surface Technologies and uneven order trends present challenges. The …

Pfizer Inc. Passt Gewinnprognose für 2026 an

PFE Q2 Earnings Top, 2026 Sales View Tweaked, COVID Forecast Cut

Pfizer PFEreported second-quarter 2026 adjusted earnings per share of 77 cents, which beat the Zacks Consensus Estimate of 68 cents per share. Earnings were flat year over year. Revenues came in at $15.03 billion, up 3% from the year-ago quarter on a reported basis …

Pfizer's Recovery Story Is Starting to Look More Durable

This article first appeared on GuruFocus. Pfizer Inc. (PFE, Financials), the pharmaceutical firm, said its second-quarter earnings topped Wall Street estimates and boosted its annual revenue guidance, as growth in its non-COVID portfolio compensated for a steep drop in Paxlovid sales.Adjusted earnings of 77 …

Pfizer Ducks Continued Covid Fallout As Hard-Fought Obesity Readout Looms

Pfizer beat second-quarter expectations Tuesday, offsetting a continued steep decline for its Covid products. But Pfizer stock fell. Continue Reading

Compared to Estimates, Pfizer (PFE) Q2 Earnings: A Look at Key Metrics

Pfizer (PFE) reported $15.03 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 2.6%. EPS of $0.77 for the same period compares to $0.78 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $14.45 billion, …

NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before …

Is Pfizer (PFE) A Bargain Following Its Earnings Beat And 2026 Guidance Lift?

Pfizer’s (NYSE:PFE) Q2 CY2026: Beats On Revenue

Pfizer's (NYSE:PFE) Q2 CY2026: Beats On Revenue Global pharmaceutical company Pfizer (NYSE:PFE) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 2.6% year on year to $15.03 billion. The company expects the full year's revenue to be around $61.5 billion, …

Pfizer (PFE) Reports Positive Phase 3 LITFULO Data In Vitiligo

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Pfizer (NYSE:PFE) reported positive Phase 3 results for LITFULO in nonsegmental vitiligo. The company plans to pursue global regulatory filings for LITFULO as …

Pharma-Zahlen im Kontrast: BioNTech schockt mit Prognose - Pfizer schafft die Überraschung

Pfizer Post Loss on Higher Revenue

Pfizer reported a second-quarter loss of $248 million, or 4 cents a share, despite a 3% increase in revenue to $15.03 billion. The company's revenue growth was driven by its oncology business, which helped to offset declining sales of its Covid-19 products. This contrasts …

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand. Continue Reading

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Focused Execution Drove 18% Operational Revenue Growth of Launched and Acquired Products(1) Advancing Robust Late-Stage Pipeline, with Several Key Pivotal Readouts Expected Over Next 12 Months Announces Expansion of Productivity Enhancement Initiatives NEW YORK, August 04, 2026--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results …

Caterpillar, Pfizer and 3 Stocks to Watch Heading Into Tuesday

As U.S. stock futures trade higher, several companies are poised for investor attention on Tuesday. Caterpillar (NYSE: CAT) and McDonald's (NYSE: MCD) are expected to report quarterly earnings, while Palantir Technologies (NASDAQ: PLTR), Snap Inc (NYSE: SNAP), and Pfizer Inc (NYSE: PFE) have already …

Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer beat Wall Street expectations for its second-quarter 2026 earnings and raised its full-year revenue guidance midpoint. The company reported adjusted earnings of $0.77 per share and revenue of $15.03 billion, driven by growth in new and acquired products, which offset declines in its …

TechnipFMC plc $FTI Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in TechnipFMC plc ($FTI) by 7.5% in the first quarter, selling over 312,000 shares but retaining a significant holding. Despite this sale, institutional investors collectively own 96.58% of the company, and analysts generally maintain a "Moderate …

Pfizer (PFE) Q2 Earnings and Revenues Top Estimates

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Pfizer eleva su previsión de ventas para 2026 tras sólidos resultados trimestrales

Pfizer’s Quarterly Results Beat Expectations on Cancer, Heart Drugs

OppFi: Look Beyond Q2, As Greenlighting Of The BNC Deal Is Not Certain (NYSE:OPFI)

TechnipFMC PLC (FTI) Shares Fall 3.5% -- GF Value Says Still Overvalued

TechnipFMC PLC (FTI) shares dropped 3.5% to $69.19, despite a strong year-to-date performance. According to GuruFocus's GF Value, the stock is significantly overvalued at $69.19 compared to its intrinsic value of $38.42. Insider selling and a high P/E ratio compared to historical averages further …

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S Revenue Breakdown – NEO:PFE

This article provides a revenue breakdown for Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S (NEO:PFE). It highlights that the United States was the primary contributor to the company's revenue, generating ‪51.81 billion CAD last year and ‪53.01 billion CAD …

July Social Media Round-Up—America 250, Pfizer Futures, and More

This article provides a round-up of Pfizer's social media activities in July, highlighting various discussions, achievements, and scientific insights. It covers topics like living with alopecia areata, a Pfizer colleague's cancer survival story, and reflections on scientific advancements. The summary also notes leadership updates, …

Why (YPF) Price Action Is Critical for Tactical Trading

This article from Stock Traders Daily discusses why YPF's price action is critical for tactical trading, highlighting strong sentiment across all horizons and an exceptional 39.9:1 risk-reward setup. It outlines three distinct AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, …

Pacer Advisors Inc. Sells 1,779,607 Shares of TechnipFMC plc $FTI

Pacer Advisors Inc. reduced its stake in TechnipFMC plc by 53.8% in the first quarter, selling over 1.7 million shares but still holding 1.5 million shares valued at $105.7 million. Despite this institutional selling, TechnipFMC reported strong Q2 results, exceeding analyst expectations for earnings …

The Manufacturers Life Insurance Company Sells 27,983 Shares of TechnipFMC plc $FTI

The Manufacturers Life Insurance Company reduced its stake in TechnipFMC plc by 11.1% in the first quarter, selling 27,983 shares and now owning 223,353 shares valued at $15.44 million. Other institutional investors also adjusted their holdings, with 96.58% of the stock owned by hedge …

Pfizer (PFE) Q2 Earnings: What To Expect

Pfizer (PFE) Q2 Earnings: What To Expect Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings this Tuesday before market hours. Here's what to expect. Pfizer beat analysts' revenue expectations last quarter, reporting revenues of $14.45 billion, up 5.4% year on year. It was …

TECAD Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the TechnipFMC plc (TECAD) 4.0% bond maturing on June 14, 2032. It details the current coupon rate of 4.00% and indicates that the next interest payment is scheduled for June 14, 2027. The article also mentions the …

ETFs Investing in Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs Stocks

This article lists ETFs that hold Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs stocks, highlighting one specific fund: the CTBC Global High Dividend ETF Securities Investment Trust Fund. It provides financial details such as market value, weight, issuer, management style, expense ratio, …

Janus Henderson Group PLC Raises Stake in TechnipFMC plc $FTI

Janus Henderson Group PLC increased its stake in TechnipFMC plc by 28.6% in the first quarter, acquiring an additional 205,637 shares to own a total of 924,838 shares valued at approximately $64 million. This move is part of a broader trend where institutional investors …

Argent Capital Management LLC Makes New $7 Million Investment in TechnipFMC plc $FTI

Argent Capital Management LLC recently invested approximately $7 million in TechnipFMC plc, purchasing 101,184 shares during the first quarter. TechnipFMC exceeded second-quarter expectations with adjusted EPS of $0.91 and revenue of $2.76 billion, leading analysts to maintain a "Moderate Buy" rating with a consensus …

CTC Alternative Strategies Ltd. Takes Position in TechnipFMC plc $FTI

CTC Alternative Strategies Ltd. has acquired 16,223 shares of TechnipFMC plc, valued at approximately $1.12 million, making it their seventh-largest portfolio holding. TechnipFMC (NYSE:FTI) recently reported strong Q2 earnings of $0.91 EPS, surpassing consensus estimates, with a 9% year-over-year revenue increase to $2.76 billion. …

California State Teachers Retirement System Grows Stock Holdings in TechnipFMC plc $FTI

The California State Teachers Retirement System increased its stake in TechnipFMC plc (NYSE:FTI) by 20.9% in the first quarter, now owning 470,339 shares valued at $32.5 million. Other institutional investors also adjusted their holdings, and the company recently announced strong Q2 2026 earnings, beating …